BioAge Labs

Overview

BioAge Labs is a clinical-stage biotechnology company based in Richmond, California, founded in 2015. The company focuses on developing therapies that address the biological mechanisms of aging to treat metabolic and cardiometabolic diseases, such as obesity. Utilizing a proprietary computational platform, the company analyzes extensive human aging data to discover new biological targets and druggable pathways related to aging and age-related diseases.

The lead clinical program, Azelaprag (BGE-102), is an oral APJ receptor agonist aimed at treating obesity in older adults. Azelaprag is currently entering Phase 2 clinical trials in combination with tirzepatide to enhance weight loss and improve body composition. BioAge Labs is also advancing several preclinical candidates that target metabolic aging pathways, focusing on chronic inflammation and insulin resistance. The company is dedicated to improving health outcomes for older adults suffering from metabolic diseases through innovative therapies.

Basic Information

Contact Details

• Phone: +1 510-806-1445
• Website: bioagelabs.com
• LinkedIn: linkedin.com/company/bioage-labs

Key Focus Areas & Initiatives

• Aging research and longevity
• Biotechnology and therapeutic development
• Metabolic and cardiometabolic disease treatment
• Obesity treatment in older adults
• Omics-driven drug discovery
• Targeting root causes of aging
• Precision medicine and personalized therapies
• Clinical trials: Azelaprag (BGE-102), APJ receptor agonist
• Molecular targets and systems biology modeling
• Biomarker discovery and validation
• Data analytics and machine learning applied to aging
• Chronic inflammation and insulin resistance interventions
• Multi-omics data integration
• Biopharmaceutical innovation
• Development of therapeutic candidates

Technologies Used

• AI
• CloudFlare Hosting
• Cloudflare DNS
• Gmail
• Google Apps
• Microsoft Office 365
• Mobile Friendly
• Remote

Affiliated Organizations & Regional Branches